Lipoprotein(a) optimal range and reference range

Compiled by Alina Radu, founder of Sera, from the published sources below · Last reviewed November 9, 2026

Sera's bands for Lipoprotein(a):

  • Optimal 0 – 75 nmol/L (0 – 30 mg/dL); sufficient 0 – 125 nmol/L (0 – 50 mg/dL); out of range above 125 nmol/L.

Evidence grade: Established clinical threshold. A band edge that corresponds to a recognised diagnostic, risk or treatment threshold from a major clinical guideline or public-health body.

All units

UnitOptimalSufficientOut of range
nmol/L0 – 750 – 125above 125
mg/dL0 – 300 – 50above 50
g/L0 – 0.30 – 0.5above 0.5

Bounded on the high side only — a low result is not treated as out of range. Risk rises with the level; a low Lp(a) is the favourable direction.

What the evidence says

The optimal band ends at 75 nmol/L (30 mg/dL, 0.30 g/L), below which the EAS consensus rules risk out, and the acceptable band at 125 nmol/L (50 mg/dL, 0.50 g/L), above which it rules risk in. The 2026 ACC/AHA guideline uses the same upper figure as a risk-enhancing factor. Lp(a) is largely genetically determined and stable through life, so a single measurement is usually sufficient. g/L and mg/dL are the same mass measurement on different scales (1 g/L = 100 mg/dL). The nmol/L and mass figures are paired cut-offs from different assays, not conversions of one another.

Sources

  • Leistungsverzeichnis Lipoprotein(a) FB-PÄ 6 LPa OE — Universitätsklinikum Ulm, Zentrale Einrichtung Klinische Chemie, 2022 · Laboratory / reference-interval sourceGerman university laboratory directory, revision of 11 March 2022. It states Lp(a) mass in mg/dl with g/l in brackets and links values above about 30 mg/dl (0,3 g/l) with higher atherosclerosis risk, which equals Sera's optimal upper edge of 0.30 g/L. It also cites the EAS recommended range of below 50 mg/dl. The laboratory itself now reports in nmol/l.
  • Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement — European Atherosclerosis Society — European Heart Journal, 2022 · Professional societySuggests Lp(a) cut-offs to rule risk out below 30 mg/dL (75 nmol/L) and to rule it in above 50 mg/dL (125 nmol/L), with the range between as a grey zone. The two edges Sera's bands end on.
  • Guideline on the Management of Dyslipidemia — American College of Cardiology / American Heart Association, 2026 · Clinical guidelineLDL goals set by cardiovascular risk: below 100 mg/dL at borderline or intermediate risk, below 70 at high risk, and below 55 with non-HDL below 85 at very high risk. Replaces the 2018 cholesterol guideline, and is the reason Sera's LDL band is a review aid and not a treatment goal.

What Lipoprotein(a) [Lp(a)] measures

A cholesterol-carrying particle whose level is set mostly by your genes.

An independent risk factor for heart disease. Because it is largely genetic, it is hard to change with lifestyle alone.

Related heart health markers

See Lipoprotein(a) in the full list of biomarker ranges

About the author

Alina Radu is the founder of Sera and a software engineer. The idea started with her own Hashimoto's tests, scattered across years without the big picture. She is not a clinician: these ranges are compiled from the published sources linked on each page, with every source named. Alina Radu on LinkedIn

This page is a reference for practitioners, not medical advice. Sera's bands are practitioner targets for structured review, not diagnostic thresholds, and Sera does not diagnose or recommend treatment. Read a result alongside the interval printed by the issuing laboratory and the client's history and symptoms. Range set: Sera Production, version 1.0, last reviewed November 9, 2026.